Dr. Srinivasa Tejaswini Adada Specialist in Medical Oncology

Introduction

Dr. Srinivasa Tejaswini Adada is a skilled medical oncologist practicing at HCG Cancer Centre, Visakhapatnam. She has a total of 12 years experience. She has completed her DM in medical oncology, along with fellowships like MRCP-UK and ECMO, Dr. Tejaswini firmly believes in delivering the highest-quality care and support to her patients. She has a special interest in clinical research and has participated in many conferences and oral and poster presentations. Along with being a talented medical oncologist in Visakhapatnam, Dr. Tejaswini fosters the next generation of cancer specialists through her research and mentorship of postgraduate students.

Area of Expertise

● Dr. Srinivasa Tejaswini Adada is a trained medical oncologist who specializes in the management of solid malignancies and hematological malignancies.

● Her expertise also extends to the administration of systemic therapies, such as chemotherapy, targeted therapy, and immunotherapy, to manage a broad spectrum of cancers.

●She is extensively trained in administering hematopoietic stem cell transplants, which include autologous and allogeneic transplants (including haploidentical and MUD transplants).

● By creating a platform for open communication, Dr. Tejaswini ensures that every question and concern of her patients is addressed and that they are confident about their treatment from the beginning.

Research & Publications

As a leading cancer hospital in Visakhapatnam, HCG Cancer Centre believes that innovation is crucial for us to have an upper hand against cancer. Many specialists in our network, including Dr. Tejaswini, are actively involved in clinical research and trials and participate in conferences to present them. The following are a few of the many presentations and publications that are under the name of Dr. Tejaswini:

⮚ T., Adadadara., S., K., Majumdar., Vinayak, V, Maka., Sanjay, Kumar. (2022). 442P Dose intensity and tolerance of modified FOLFIRINOX in patients with advanced cancer. Annals of Oncology, 33: S1612-S1612. doi: 10.1016/j.annonc.2022.10.473.

● Thesis

⮚ The Study of Risk Factors, Symptomatology and Radiological Profile in Posterior Circulation Stroke.

● Oral and Poster Presentations

⮚ Poster presentation in APICON 2018; Bangalore, National conference Titled: Pyrexia of Unknown Origin: Rare Presentation of Adult Onset Still Disease.

⮚ Poster presentation in APICON 2018; Bangalore, National conference Titled: Pyrexia of Unknown Origin in a Young Girl: Rheumatoid Nodules.

⮚ Oral Paper Presentation at Indian Society of Medical and Pediatric Oncology (ISMPO) ISOCON2022 Conference; Chennai, October 2022 Titled: Dose Intensity and Tolerance of the Modified Folfirinox Regimen in Patients with Advanced Cancer.

⮚ Delegate to the Lymphoma Workshop –Joint Conference of ISMPO-ISOCON 2022 at the Hilton Hotel Chennai, India.

⮚ Poster Presentation at the European Society of Medical Oncology (ESMO) International Conference in December 2022, Titled: Dose Intensity and Tolerance of Modified FOLFIRINOX Regimen in Patients with Advanced Cancer

⮚ Participated in the 4th Annual Meeting of the Indian Society for Blood & Marrow Transplantation (ISBMT 2023).

Other Doctors